Dr. Nalini Rajamannan of Sacred Heart Cardiology, Chicago IL, notes that Chromadex offers a very important aspect in the field of approaching hypertension and hyperlipidemia in patients who are at risk or who have these disease processes."Basic science and future clinical trials in treating patients will provide critical information for these products to try and slow the progression of heart disease," said Rajamannan."
Chromadex, The Potential "Game Changer" In Patient Dependency Of The Multi-Billion Dollar Pharmaceutical Industry
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts